{"id":731894,"date":"2023-02-15T16:37:58","date_gmt":"2023-02-15T21:37:58","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/"},"modified":"2023-02-15T16:37:58","modified_gmt":"2023-02-15T21:37:58","slug":"conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/","title":{"rendered":"Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation"},"content":{"rendered":"<h2>\nConformis and Bodycad Settle Litigation Related to Bodycad\u2019s Patient-Specific Instruments and Implants<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">BILLERICA, Mass., Feb.  15, 2023  (GLOBE NEWSWIRE) &#8212; Conformis, Inc. (NASDAQ:CFMS) along with Bodycad Laboratories, Inc. and Bodycad USA Corp. announced today that they have entered into a settlement and license agreement that resolves the patent infringement dispute filed by Conformis in June of 2021.<\/p>\n<p align=\"left\">Conformis and Bodycad are pleased to have resolved their ongoing patent litigation. The companies have amicably agreed to an undisclosed amount for the dismissal of all patent litigation between the companies along with a release and license to certain Conformis patents related to patient-specific instrumentation and knee implants.<\/p>\n<p align=\"left\">\n        <strong><br \/>\n          <u>About Conformis, Inc.<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"left\">Founded in 2004, Conformis is a medical technology company focused on advancing orthopedic patient care and creating a world without joint pain. Its product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant\u00ae Platinum Services\u2120 Program, as well as data-informed, standardized solutions that combine many benefits of personalization with the convenience and flexibility of an off-the-shelf system. Conformis\u2019 sterile, just-in-time, Surgery-in-a-Box\u2122 delivery system is available with all of its implants and personalized, single-use instruments. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.<\/p>\n<p align=\"left\">For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F80yE0b4NwHd0-IAG3RNZV7zTtTyfDituL0HyeKP9Rir4ZXLIfDpCoz0UnA2jI9uHFKq7jNQIlPJvEs8lFt0Fg==\" rel=\"nofollow noopener\" target=\"_blank\">www.conformis.com<\/a>. To receive future releases in e-mail alerts, sign up at ir.conformis.com.<\/p>\n<p align=\"left\">CONTACT:<br \/>Investor Contact<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ze1pZBZn8LFg_esFLFGslDF6td41sRrTAz9J7RBmemqZUcvtoILIuKxJlW7821e6XldaS0xStKm-aZ9PQ01xYA==\" rel=\"nofollow noopener\" target=\"_blank\">ir@conformis.com<\/a>\u00a0<br \/>+1 (781) 374-5598<\/p>\n<p align=\"left\">\n        <strong><br \/>\n          <u>About Bodycad Laboratories, Inc.<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p>\n        <em>Bodycad is a Canadian company that is transforming the current standards in orthopaedic implants to help surgeons and patients achieve their mutual goal of a perfect Personalized Restoration\u2122.\u00a0With the help of Bodycad\u2019s proprietary software, its integrated planning process as well as its fully vertically integrated manufacturing facility, surgeons can quickly and efficiently achieve specific design plans and personalized restorations based on the precise anatomical specifications of their patients. Bodycad\u2019s unique\u00a0approach offers patients and surgeons the potential of greater comfort, fit and durability, thereby making the pursuit of orthopaedic perfection possible. Learn more at\u00a0<\/em><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cqMAUHQ_oieQ2zCotLpU4qHHn7TytJ-521yMGV7bBy12IavC1ap_sp-zsFyeXcfKor0JDnbdiUNW3gdSS8d-jg==\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <em>www.bodycad.com<\/em><br \/>\n        <\/a><br \/>\n        <em>.<\/em>\n      <\/p>\n<p>CONTACT:<br \/>Corporate Headquarters<br \/>+1 (866) 527-1388<\/p>\n<p>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0OTU1NSM1NDA5Nzk5IzIwMTg3MjU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MzdmNTA5YjYtNzU3My00MDcxLWI3MDctMWU1ZTdhYmIwNWQ0LTEwMzAyOTg=\/tiny\/Conformis-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Conformis and Bodycad Settle Litigation Related to Bodycad\u2019s Patient-Specific Instruments and Implants BILLERICA, Mass., Feb. 15, 2023 (GLOBE NEWSWIRE) &#8212; Conformis, Inc. (NASDAQ:CFMS) along with Bodycad Laboratories, Inc. and Bodycad USA Corp. announced today that they have entered into a settlement and license agreement that resolves the patent infringement dispute filed by Conformis in June of 2021. Conformis and Bodycad are pleased to have resolved their ongoing patent litigation. The companies have amicably agreed to an undisclosed amount for the dismissal of all patent litigation between the companies along with a release and license to certain Conformis patents related to patient-specific instrumentation and knee implants. About Conformis, Inc. Founded in 2004, Conformis is a medical technology company focused on advancing &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-731894","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Conformis and Bodycad Settle Litigation Related to Bodycad\u2019s Patient-Specific Instruments and Implants BILLERICA, Mass., Feb. 15, 2023 (GLOBE NEWSWIRE) &#8212; Conformis, Inc. (NASDAQ:CFMS) along with Bodycad Laboratories, Inc. and Bodycad USA Corp. announced today that they have entered into a settlement and license agreement that resolves the patent infringement dispute filed by Conformis in June of 2021. Conformis and Bodycad are pleased to have resolved their ongoing patent litigation. The companies have amicably agreed to an undisclosed amount for the dismissal of all patent litigation between the companies along with a release and license to certain Conformis patents related to patient-specific instrumentation and knee implants. About Conformis, Inc. Founded in 2004, Conformis is a medical technology company focused on advancing &hellip; Continue reading &quot;Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-15T21:37:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0OTU1NSM1NDA5Nzk5IzIwMTg3MjU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation\",\"datePublished\":\"2023-02-15T21:37:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\\\/\"},\"wordCount\":359,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0OTU1NSM1NDA5Nzk5IzIwMTg3MjU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\\\/\",\"name\":\"Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0OTU1NSM1NDA5Nzk5IzIwMTg3MjU=\",\"datePublished\":\"2023-02-15T21:37:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0OTU1NSM1NDA5Nzk5IzIwMTg3MjU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0OTU1NSM1NDA5Nzk5IzIwMTg3MjU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/","og_locale":"en_US","og_type":"article","og_title":"Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation - Market Newsdesk","og_description":"Conformis and Bodycad Settle Litigation Related to Bodycad\u2019s Patient-Specific Instruments and Implants BILLERICA, Mass., Feb. 15, 2023 (GLOBE NEWSWIRE) &#8212; Conformis, Inc. (NASDAQ:CFMS) along with Bodycad Laboratories, Inc. and Bodycad USA Corp. announced today that they have entered into a settlement and license agreement that resolves the patent infringement dispute filed by Conformis in June of 2021. Conformis and Bodycad are pleased to have resolved their ongoing patent litigation. The companies have amicably agreed to an undisclosed amount for the dismissal of all patent litigation between the companies along with a release and license to certain Conformis patents related to patient-specific instrumentation and knee implants. About Conformis, Inc. Founded in 2004, Conformis is a medical technology company focused on advancing &hellip; Continue reading \"Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/","og_site_name":"Market Newsdesk","article_published_time":"2023-02-15T21:37:58+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0OTU1NSM1NDA5Nzk5IzIwMTg3MjU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation","datePublished":"2023-02-15T21:37:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/"},"wordCount":359,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0OTU1NSM1NDA5Nzk5IzIwMTg3MjU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/","name":"Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0OTU1NSM1NDA5Nzk5IzIwMTg3MjU=","datePublished":"2023-02-15T21:37:58+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0OTU1NSM1NDA5Nzk5IzIwMTg3MjU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0OTU1NSM1NDA5Nzk5IzIwMTg3MjU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/conformis-inc-bodycad-laboratories-inc-and-bodycad-usa-corp-announce-settlement-of-patent-litigation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/731894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=731894"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/731894\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=731894"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=731894"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=731894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}